Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SCREENING

Peridiagnostic and cascade cancer genetic testing

Nature Reviews Clinical Oncology volume 17, pages 277–278 (2020)Cite this article

Subjects

The identification of individuals carrying cancer susceptibility genetic variants could be improved by peridiagnostic cancer genetic testing and cascade testing of the relatives of patients diagnosed with cancer. Herein we discuss two studies that highlight the importance of active involvement of the medical team, both in informing the relatives and offering pre-test telephone genetic counselling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Turnbull, C., Sud, A. & Houlston, R. S. Cancer genetics, precision prevention, and a call to action. Nat. Genet. 50, 1212–1218 (2018).

    Article  CAS  Google Scholar 

  2. Offit, K. et al. Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening. J. Clin. Oncol. https://doi.org/10.1200/JCO.19.02010 (2020).

    Article  PubMed  Google Scholar 

  3. Frey, M. K. et al. Prospective feasibility trial of a novel strategy of facilitated cascade genetic testing using telephone counseling. J. Clin. Oncol. https://doi.org/10.1200/JCO.19.02005 (2020).

    Article  PubMed  Google Scholar 

  4. Evans, D. G. et al. Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin. Genet. 75, 124–132 (2009).

    Article  CAS  Google Scholar 

  5. Brooks, L. et al. BRCA1/2 predictive testing: a study of uptake of two centres. Eur. J. Hum. Genet. 12, 654–662 (2004).

    Article  Google Scholar 

  6. Fehniger, J., Lin, F., Beattie, M. S., Joseph, G. & Kaplan, C. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. J. Genet. Counsel 22, 603–612 (2013).

    Article  Google Scholar 

  7. Møller, P. et al. Genetic epidemiology of BRCA mutations — family history detects less than 50% of the mutation carriers. Eur. J. Cancer 43, 1713–1717 (2007).

    Article  Google Scholar 

  8. Hoskins, P. J. & Gotlieb, W. H. Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: a review of the literature. CA Cancer J. Clin. 67, 493–506 (2017).

    Article  Google Scholar 

  9. US Preventive Services Task Force. Risk assessment, genetic counselling and genetic testing for BRCA related cancer. US Preventive services Task Force recommendation statement. JAMA 322, 652–665 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK

    Nora Pashayan

  2. Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK

    Clare Turnbull

  3. Genomics England, Queen Mary University of London, London, UK

    Clare Turnbull

Authors
  1. Nora Pashayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Clare Turnbull
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nora Pashayan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pashayan, N., Turnbull, C. Peridiagnostic and cascade cancer genetic testing. Nat Rev Clin Oncol 17, 277–278 (2020). https://doi.org/10.1038/s41571-020-0348-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-020-0348-4

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer